Ulobetasol (INN) or halobetasol (USAN) is a corticosteroid used to treat psoriasis. It is a group I corticosteroid under the US classification, the most potent class of such drugs. Halobetasol propionate is usually supplied as a 0.05% topical cream.
![]() | |
Clinical data | |
---|---|
Other names | (6S,8S,9S,10S,11S,13S,14S,16S,17R)-17-(2-Chloroacetyl)-6,9-difluoro-11,17-dihydroxy-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one |
AHFS/Drugs.com | Micromedex Detailed Consumer Information |
MedlinePlus | a601060 |
ATC code | |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
KEGG | |
ChEMBL | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C22H27ClF2O4 |
Molar mass | 428.897 g·mol−1 |
3D model (JSmol) | |
| |
| |
![]() ![]() |
External links
- halobetasol at the U.S. National Library of Medicine Medical Subject Headings (MeSH)